°¨¿°Áúȯ ½ÃÀåÁ¶»çº¸°í¼­

°¨¿°Áúȯ(Infectious Disease)¿¡ ´ëÇÑ Á¤ºÎ¿Í ¹Î°£ÀÇ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ °¨¿°Áúȯ °ü·Ã ¾÷°è ¶ÇÇÑ È°È²À» ¶ì°í ÀÖ½À´Ï´Ù. Áúº´ °Ë»ç, ¹é½Å, Ä¡·á¹ý, ¿¬±¸°³¹ß(R&D)¿¡ ´ëÇÑ ¸ðµç Á¤º¸ ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇØ ÃֽŠÁ¶»ç º¸°í¼­¸¦ ±¸ºñÇÏ°í °ü·Ã ±â¼ú°ú ½ÃÀå¿¡ ´ëÇÑ ÃֽŠÁ¤º¸¸¦ ÀüÇØµå¸®°í ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 1,026°Ç)
¼¼°èÀÇ °¨¿°Áõ ºÐÀÚÁø´Ü ½ÃÀå º¸°í¼­(2025³â)
Infectious Disease Molecular Diagnostics Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,294,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °¨¿° °ü¸® °¨½Ã ¼Ö·ç¼Ç ½ÃÀå º¸°í¼­(2025³â)
Infection Control Surveillance Solutions Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,294,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Å©¸³ÅäÄÛÄí½ºÁõ Ä¡·áÁ¦ ½ÃÀå º¸°í¼­(2025³â)
Cryptococcosis Therapeutics Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,294,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ¹ÙÀÌ¿ÀÇʸ§ ÇÁ·ÎÅØÅÍ ½ÃÀå ¿¹Ãø(-2032³â) : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®
Probiotic Biofilm Protectors Market Forecasts to 2032 - Global Analysis By Product Type (Probiotic Strains, Postbiotics & Synbiotics and Delivery Formats), Application, End User and By Geography
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,150 £Ü 5,817,000 (ºÎ°¡¼¼ º°µµ)
¶óÀÓº´ ¹é½Å ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø ¹× °æÀï ºÐ¼®(-2031³â)
Lyme Disease Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 3,850 £Ü 5,397,000 (ºÎ°¡¼¼ º°µµ)
H1N1 ¹é½Å ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
H1N1 Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,850 £Ü 5,397,000 (ºÎ°¡¼¼ º°µµ)
ÁöÄ«¿­ ¹é½Å ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Zika Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,850 £Ü 5,397,000 (ºÎ°¡¼¼ º°µµ)
Ç×±ÕÁ¦ ½ÃÀå : ¾à¹° Á¾·ùº°, Åõ¿© °æ·Îº°, ºÐÀÚ À¯Çüº°, Ȱ¼º ½ºÆåÆ®·³º°, ÀÛ¿ë±âÀüº°, Á¦Çüº°, ÀûÀÀÁõº°, ÆÇ¸Å °ÅÁ¡º°, À¯Åë ä³Îº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Antibacterial Drugs Market by Drug Class, Route Of Administration, Molecule Type, Spectrum Of Activity, Mechanism of Action, Formulation, Indication, Point of Sale, Distribution Channel - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,522,000 (ºÎ°¡¼¼ º°µµ)
½º¸¶Æ® ³ó¾÷ °ø±Þ¸Á ½ÃÀå : ±¸¼º¿ä¼Ò, ±â¼ú, Àü°³ ¹æ½Ä, ÀÛ¹° À¯Çü, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Smart Agricultural Supply Chains Market by Component, Technology, Deployment Mode, Crop Type, Application - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,522,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÄÉÅäÄÚ³ªÁ¹(Ketoconazole) ½ÃÀå
Ketoconazole
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °£¿° °Ë»ç ¹× Áø´Ü ½ÃÀå : ½ÃÀå ±Ô¸ð ºÐ¼® - °Ë»çº°, ±â¼úº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global Hepatitis Testing/Diagnosis Market Size study & Forecast, by Test (Blood Test, Imaging Tests, Liver Biopsy), Technology (ELISA, Rapid Diagnostic Test, PCR), End-use and Regional Forecasts 2022-2032
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,950 £Ü 6,939,000 (ºÎ°¡¼¼ º°µµ)
Ä­µð´ÙÁú¿° Ä¡·á ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ¾àÁ¦ Ŭ·¡½ºº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Vulvovaginal Candidiasis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Drug Class, By Route of Administration, By Distribution Channel, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,500 £Ü 6,308,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àμö°øÅë°¨¿°Áõ Ä¡·á ½ÃÀå
Zoonotic Disease Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³ë·Î¹ÙÀÌ·¯½º Áø´Ü ½ÃÀå
Norovirus Diagnostics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¹ÙÀÌ·¯½ºÇÐ ¹× ¼¼±ÕÇÐ ½ÃÀå
Virology and Bacteriology
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÇÁ¸®¿Âº´ Ä¡·á ½ÃÀå
Prion Disease Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÓÇöõÆ® ÁÖÀ§¿° ½ÃÀå
Peri-Implantitis
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Æä´Ï½Ç¸° ½ÃÀå
Penicillin
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¿¥Æø½º Ä¡·á ½ÃÀå
Mpox Therapeutics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ HIV °ü·Ã Áö¹æÀÌ¿µ¾çÁõ ½ÃÀå
HIV-Associated Lipodystrophy
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ BÇü ¹× CÇü °£¿° Áø´Ü¾à ½ÃÀå
Hepatitis B and C Diagnostics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ »ó±âµµ °¨¿° Ä¡·á ½ÃÀå
Upper Respiratory Tract Infection Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¸Åµ¶ ¸é¿ªºÐ¼®¹ý Áø´Ü¾à ½ÃÀå
Syphilis Immunoassay Diagnostics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Å¥¿­ ½ÃÀå
Q Fever
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Áֱ⼺ ¹ß¿­ ÁõÈıº ½ÃÀå
Periodic Fever Syndrome
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,201,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.